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http:WHAT THIS PAPER ADDS
Endovascular intervention for thoracic aortic pathology is now established as an alternative to open surgery.
However the effect of pathology on outcome requires further investigation. In this study we evaluated 309
consecutive patients in a single centre over a 14-year period and showed no difference in the incidence of all-
cause mortality, stroke, and spinal cord ischaemia between patients with aneurysm and dissection. There was
however a high rate of aortic-related death in the dissection group, which may indicate the need to reﬁne the
future clinical management of these patients, including endograft design and procedural technique.Objectives: Endovascular intervention is established for treatment of thoracic aortic dissection and aneurysm.
The aim of this study was to compare the incidence of all-cause and aortic-related in-hospital mortality, stroke,
spinal cord ischaemia, and major adverse event rate for patients undergoing thoracic aortic endovascular
intervention to see if there is a pathology-speciﬁc effect.
Methods: Data were collected prospectively and analysed retrospectively for a cohort of 309 consecutive
patients with either thoracic aortic dissection or aneurysm over a 14-year period.
Results: There were 209 men and 100 women with a median age of 72 years (interquartile range [IQR] 63e78
years). Aneurysm affected 62% (193/309) of patients and 37% (116/309) had complicated type B aortic
dissection, of whom 43% (50/116) had acute and 57% (66/116) chronic presentations. In patients with aortic
dissection compared to aneurysm, there was no signiﬁcant difference in all-cause in-hospital mortality (6.9% vs.
8.3% respectively, p ¼ 0.827, relative risk [RR] 0.83, 95% conﬁdence interval [CI] 0.37e1.88), stroke (6.0% vs
6.2%, p ¼ 1.00, RR 0.971, CI 0.39e2.39), spinal cord ischaemia (6.0% vs 6.2%, p ¼ 1.00, RR 1.030, CI 0.42e2.54),
or major adverse event rate (16.4% vs. 16.6%, p ¼ 1.00, RR 0.988, CI 0.59e1.66). The rate of aortic related death
was four times greater in the dissection than in the aneurysm group (4/8 ¼ 50% vs 2/16 ¼ 12.5%, p ¼ 0.06, RR
6.99, CI 0.92e52.5) although this did not reach statistical signiﬁcance.
Conclusions: There was no difference in the incidence of in-hospital mortality, stroke, and spinal cord ischaemia
between aneurysm and dissection. The higher rate of aortic related death in the dissection group may indicate
the need to reﬁne the clinical management of these patients, including procedural planning, endograft design,
and operative technique.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Endovascular intervention for thoracic aortic pathology is
now established as an alternative treatment to open sur-
gery and in recent years the number of thoracic endovas-
cular procedures has risen each year.1 The increased use of
endovascular repair has been driven by the early mortality
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//dx.doi.org/10.1016/j.ejvs.2014.04.004with open surgical treatment of the thoracic aorta.2,3
Endovascular stent grafts and delivery systems were
initially designed for treatment of aneurysmal disease of the
thoracic aorta and were subsequently used by Dake and
Nienaber in 1999 for treatment of aortic dissection, without
any signiﬁcant change in biomechanical properties or
design.4,5 Given the spectrum of different pathologies that
affect the descending thoracic aorta, it is important to
deﬁne whether the outcome of endovascular repair is pa-
thology speciﬁc to reﬁne procedural technique and
endograft design.
The aim of this study was to compare the rate of all-cause
and aortic related in-hospital mortality, stroke, spinal cord
ischaemia, and major adverse event rate (composite end-
point of mortality, stroke, and spinal cord ischaemia) for
patients undergoing thoracic endovascular intervention for
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was a pathology-speciﬁc effect.METHODS
The cohort consisted of 309 consecutive patients with
thoracic aortic aneurysm and complicated type B aortic
dissection who underwent endovascular treatment in a 14-
year period at a single university teaching hospital. Aneu-
rysms which affected the aortic arch and descending
thoracic aorta were included, but those affecting the
visceral vessels (thoracoabdominal aneurysms) were
excluded. Aneurysms were treated in the presence of
symptoms or rupture, and when the maximum transverse
diameter was 6 cm or greater.
Patients with dissection presented with either acute or
chronic complicated type B dissection. Acute dissection was
deﬁned as patients treated within 14 days of symptom
onset, and chronic as 15 days or more. Complications in
acute dissection were deﬁned as rupture, end-organ
ischaemia, refractory hypertension, and continued pain
despite the best medical therapy. Complications in chronic
dissection were aortic rupture and a total aortic diameter
greater than 5.5 cm. No patient in this series had a complex
aortic procedure with a branched or fenestrated device.
Patient and procedural details were entered prospec-
tively into a database as were adverse events, including
cause of death, stroke, and spinal cord ischaemia, and were
analysed retrospectively. Patients treated non-electively
were deﬁned as urgent. Patients with mycotic aneurysm,
transection, vasculitis, and aneurysm related to coarctation
repair made up 15.5% of the database and were excluded
from this analysis due to their relatively small number.Pre-operative imaging
All patients underwent bolus-tracked contrast-enhanced
computed tomography (CT). Images were interpreted by
experienced radiologists and surgeons to determine the
anatomical suitability for endovascular repair. Anatomical
suitability was deﬁned as a landing zone of greater than or
equal to 15 mm; devices were oversized by 0e10% for
dissection and 10e30% for aneurysm depending upon the
device and surgeon preference. Duplex sonography was
used to assess the status of the carotid and vertebral ar-
teries if deliberate occlusion of the arch vessels was
planned.Initial medical management
Patients with acute aortic dissection were initially treated
with hypotensive medication and analgesia on a high-
dependency or intensive care unit. Blood pressure was
titrated to ensure adequate urine output. Patients who
were haemodynamically unstable (systolic blood pressure
<90 mmHg) were taken immediately to the endovascular
suite after a diagnostic CT scan to assess anatomical
suitability.Operative technique
A team consisting of ﬁve vascular surgeons and six inter-
ventional radiologists assessed the patients and performed
the procedures. All operations were performed in a hybrid
operating theatre with ﬂuoroscopic and angiographic
equipment available. Vascular access was achieved via
femoral arteriotomy or prosthetic conduit. A catheter was
inserted in the contralateral groin so that continuous
angiography could be performed during device deployment.
The majority of procedures were performed under loco-
regional anaesthesia without routine pre-operative place-
ment of a cerebrospinal ﬂuid (CSF) drain. Prophylactic spinal
drain insertion was considered if the procedure was per-
formed under general anaesthetic, there was long segment
coverage (the descending thoracic aorta from proximal to
the left subclavian to the coeliac axis), planned occlusion of
the left subclavian artery, extensive disease (proximal to the
left subclavian with involvement of infrarenal aorta and/or
internal iliacs); planned occlusion of the internal iliac ar-
teries, or previous infrarenal aortic repair.Adjuvant procedures
Revascularisation of the brachiocephalic and left common
carotid arteries was performed if coverage of the vessel
origin with the device was planned. Routine revascularisa-
tion of the left subclavian artery was not performed, but
was considered for each individual case. Extra-anatomic
bypass grafts were performed as a staged procedure if
the patient was elective and if they were urgent but stable.
Unstable patients had both procedures performed under
the same anaesthetic. Conduits to the common iliac artery
or infrarenal aorta were performed to bypass diseased,
stenotic, and/or tortuous iliac arteries.Deﬁnitions of outcome
In-hospital mortality was deﬁned as death in hospital after
the procedure and prior to discharge. All patients who had
any degree of paraplegia or paraparesis were classiﬁed as
having spinal cord ischaemia, even if this occurred preop-
eratively. This included patients who made a full neuro-
logical recovery. Likewise all patients with an anterior or
posterior fossa neurological deﬁcit for more than 24 hours
were classiﬁed as stroke, and this included non-disabling
and recovered strokes. All patients suspected to have a
stroke or spinal cord ischaemia were assessed by a
neurologist to conﬁrm the diagnosis. Patients with neuro-
logical events were assessed by imaging studies requested
by the neurologist (CT and/or magnetic resonance imaging
as appropriate).Statistical analysis
SPSS Statistics v20.0 (IBM Corporation, NY) software was
used for statistical analysis. Following KolmogoroveSmirnov
testing for normality, continuous variables were expressed
as medians and interquartile range (IQR) and sample dis-
tributions compared using a two-tailed ManneWhitney
Table 1. Patient demographics and operative details.
Demographics Dissection Aneurysm
n % n %
Total 116 38 193 62
Men 91 78 118 61
Median age (range) in years 66 (58e74) n/a 75 (69e80) n/a
Urgent 57 49 44 23
Operative details Median Range Median Range
Blood loss (mL) 200 50e5000 300 50e4000
Operation time (min) 83 67e114 100 80e125
Fluoro dose (Gycm2) 197 115e306 181 117e327
Contrast volume (mL) 134 100e190 140 100e180
Devices n % n %
Gore Excluder 10 9 24 12
Gore TAG (TAG, cTAG) 84 72 82 42
Medtronic AneuRx 0 0 3 2
Medtronic Talent 3 3 13 7
Medtronic Valiant 2 2 5 3
Cook TX2 8 7 50 26
Stenford 0 0 2 1
Endomed EndoFit 8 7 8 4
Bolton Relay 1 1 6 3
Single stent 59 51 52 27
>1 stent 57 49 141 73
Ishimaru zone 0e2 63 54 80 42
Ishimaru zone 3 53 46 113 58
270 R.E. Clough et al.test. The incidence of all-cause and aortic related death,
stroke, spinal cord ischaemia, and major adverse event rate
between dissection and aneurysm was assessed using
Fisher’s exact test, followed by calculation of the corre-
sponding relative risk (RR) at a 95% conﬁdence interval (CI).
A p-value <.05 was considered statistically signiﬁcant.RESULTS
Patient demographics
In total, 309 patients were included in the analysis. The
pathology, demographics and procedural details are shown
in Table 1. Overall, the maleefemale ratio was 209:100 and
the median age was 72 years (IQR 63e78 years). AneurysmTable 2. Adjuvant procedures during the primary hospital
admission.
Procedure Aneurysm Dissection Total
Carotid endarterectomy 1 0 1
Carotidecarotid bypass 17 3 20
Brachial artery exposure 1 0 1
Iliac angioplasty 2 1 3
Iliac conduit 8 1 9
Aortic conduit 4 0 4
Carotid-carotid and left
subclavian bypass
7 3 10
Carotid subclavian bypass 8 6 14
Innominate, carotid
and subclavian bypass
2 1 3
Renal artery stent 0 1 1
Femoro-femoral bypass 0 1 1
Total 50 17 67affected 62% (193/309) of patients and 37% (116/309) had
dissection, of whom 43% (50/116) had acute and 57% (66/
116) chronic dissection.
The prevalence of dissection was higher in men than in
women (43.5% vs. 25.0%, p ¼ 0.0017, RR 1.33 (95% CI
1.12e1.56)). Patients presenting with dissection were
signiﬁcantly younger (66 years, 58e74) than those pre-
senting with aneurysms (75, 69e80, p < .0001). Overall
30.1% of patients (93/309) presented urgently. Patients
were signiﬁcantly more likely to present urgently with
dissection rather than aneurysm (49.1% vs. 22.9% respec-
tively, p < .0001, RR 1.60, CI 1.32e1.94). Eleven of the 65
patients (17%) with chronic dissection were treated
urgently.Operating characteristics
The procedural technical success rate was 99.3% (307/309).
The two failures were due to inability to seal the proximal
landing zone in two patients with a symptomatic aneurysm
and a tortuous aorta. General anaesthesia was given in
21.6% (25/116) patients with dissection and 17.1% (33/193)
with aneurysm, which was not statistically signiﬁcant. The
details of the devices used are presented in Table 1.
Patients presenting with aortic dissection were signiﬁ-
cantly more likely to require placement of a stent graft in
the aortic arch (Ishimaru zones 0e2) to ensure an adequate
proximal landing zone (54.3% vs. 41.5%, p ¼ 0.034, RR 1.3,
CI 1.03e1.66). Patients with an aneurysm were more likely
to require more than one device (72.8% vs. 49.1%,
p < .0001, RR 1.48, CI 1.21e1.82). Patients presenting with
aneurysm were signiﬁcantly more likely to have a longer
Table 3. Secondary procedures during the primary hospital
admission.
Procedure Aneurysm Dissection Total
Elephant trunk and aortic
valve replacement
0 1 1
Chimney stents to arch vessels 4 0 4
Superior mesenteric
embolectomy and total colectomy
1 0 1
Further aortic stent graft(s) 2 1 3
Bilateral thoracotomy 0 1 1
Axillo-femoral bypass 1 0 1
Internal iliac artery angioplasty
to reverse spinal cord ischaemia
0 1 1
Repair iliac artery rupture 6 1 7
Femoral thrombo-embolectomy 2 0 2
Femoral patch angioplasty 6 0 6
Femoro-femoral bypass 2 1 3
Total 24 6 30
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83 [67e114] minutes respectively, p ¼ 0.0005) and longer
screening time (12.0 [8.2e18.3] vs. 8.9 [5e13.4] minutes
respectively, p ¼ 0.0001). Aneurysm patients also had
signiﬁcantly greater blood loss (300 [50e4000] vs. 200 [50e
5000] mL, p ¼ 0.0463).Adjuvant procedures during the primary hospital
admission
Sixty-seven adjuvant procedures were performed in 65 pa-
tients (Table 2), 25.9% (50/193) of the aneurysm cohort,
and 14.7% (17/116) of the dissection patients; two patients
in the aneurysm group required both a conduit and an
aortic arch debranching procedure. Brachial artery exposure
was performed in preparation for a through-and-throughTable 4. Aneurysm-related deaths.
Presentation Cause of death Device
Urgent Stroke TAG
Urgent Stroke TX2
Urgent Stroke TAG
Urgent Stroke cTAG
Urgent Myocardial infarction TX2
Urgent Myocardial infarction Exclud
Urgent Ruptured aorta Talent
Elective Stroke TX2
Elective Stroke TAG
Elective Mesenteric ischaemia Endoﬁ
Elective Mesenteric ischaemia TX1
Elective Mesenteric ischaemia Talent
Elective Mesenteric ischaemia TAG
Elective SCI, respiratory failure TAG
Elective Pneumonia TX2
Elective Ruptured aorta Endoﬁ
SCI ¼ spinal cord ischaemia.guidewire and the iliac angioplasty was used to dilate the
iliac artery for access. The renal artery was treated with a
covered stent to stop perfusion of the false lumen and the
femoro-femoral bypass was used to treat an ischaemic leg,
both in patients with dissection.Secondary procedures during the primary hospital
admission
There were 30 secondary procedures in 28 patients
(Table 3), 12.4% (24/193) of the aneurysm cohort and 5.2%
(6/116) of the dissection patients; one patient in each group
required two procedures (femoral artery reconstruction and
ilio-femoral graft). Of the aneurysm patients, one required
an axillo-femoral bypass to revascularise an ischaemic leg,
and two required further stent grafts for endoleak during
the initial hospital admission. In the dissection cohort, one
patient required an aortic valve replacement for retrograde
type A dissection, one required bilateral thoracotomy to
remove the blood to prevent cicatrisation, and one under-
went internal iliac artery angioplasty to reverse spinal cord
ischaemia.Outcomes
Death. All in-hospital deaths occurred within 30 days of the
procedure. The overall in-hospital mortality was 7.8% (24/
309) with no signiﬁcant difference in all-cause mortality
between patients presenting with dissection compared with
aneurysm (6.9% vs. 8.3% respectively, p ¼ 0.827, RR 0.83, CI
0.37e1.88). The rate of aortic related death was four times
greater in the dissection than in the aneurysm group (4/
8 ¼ 50% vs. 2/16 ¼ 12.5%, p ¼ 0.06, RR 6.99, CI 0.92e52.5)
but this did not reach statistical signiﬁcance. The causes of
death in patients with aneurysm and dissection are shownComments
Stroke territory not deﬁned
Deliberate coverage of left subclavian; no
revascularisation; massive posterior circulation
stroke
Diffuse with cardiac and respiratory failure
Diffuse brain injury
Subclavian deliberately covered to control
bleeding: Chimney stent; LIMA graft
er Coronary artery disease
Exsanguinated before second stent could be
inserted
Diffuse brain injury
Massive embolus left hemisphere; prior left
carotid endarterectomy
t Embolus
Embolus
Coeliac axis deliberately covered
Embolus
Permanent paraplegia, respiratory failure
Probable underlying lung carcinoma
t Type I endoleak; ruptured day 3
Table 5. Dissection-related deaths.
Presentation Dissection type Cause of death Device Comments
Urgent Acute Rupture of infrarenal aortic aneurysm day 7 TAG Unexpected event proven at post mortem
Urgent Chronic Rupture of infrarenal aorta TAG Failure to control bleeding from false lumen
Urgent Acute Ruptured thoracic aorta false lumen cTAG Failure to adequately cover primary entry tear
Urgent Chronic Stroke cTAG Left subclavian artery covered; carotid subclavian
bypass;
Urgent Acute Stroke cTAG No arch vessels covered; diffuse brain injury;
Urgent Acute Myocardial infarction Excluder Coronary artery disease
Urgent Acute Myocardial infarction cTAG Coronary artery disease
Elective Chronic Conversion of type B to A cTAG Caused by trauma to origin of left subclavian
artery during device insertion
272 R.E. Clough et al.in Tables 4 and 5 respectively. In the aneurysm group, the
most common cause of death was stroke, which in the
majority of cases was reported as diffuse rather than being
localised to either the anterior or posterior cerebral circu-
lation. Mesenteric ischaemia was also a common cause of
death, occurring in four of the 16 patients; in the majority,
these were thought to be embolic. There were two aortic
related deaths, one at the time of the procedure because a
second stent could not be inserted fast enough to prevent
exsanguination; the second due to persistent type I
endoleak.
The majority of dissection patients were treated urgently;
four of the eight deaths in this group were aortic related:
two in patients with acute and two in patients with chronic
dissection. The other deaths were due to stroke and
myocardial infarction.
Stroke. The overall stroke rate was 6.1% (19/309). The de-
tails of the patients who had a stroke are shown in Table 6.
There was no difference in the incidence of stroke between
dissection (7/116) compared with aneurysm (12/193) pa-
tients (6.0% vs. 6.2%, p ¼ 1.00, RR 0.971, CI 0.39e2.39).Table 6. Details of patients with stroke.
Indication Presentation Device Site
Aneurysm Urgent Talent Left hemisphere
Aneurysm Urgent TX2 Bilateral posterio
Aneurysm Urgent TAG Unknown
Aneurysm Urgent TAG Diffuse
Aneurysm Urgent cTAG Diffuse
Aneurysm Elective Excluder Right hemisphere
Aneurysm Elective Endoﬁt Right hemisphere
Aneurysm Elective TAG Left hemisphere
Aneurysm Elective TAG Right hemisphere
Aneurysm Elective TAG Right hemisphere
Aneurysm Elective TX2 Diffuse
Aneurysm Elective cTAG Unknown
Dissection Urgent Talent Right posterior
Dissection Urgent TAG Left hemisphere
Dissection Urgent cTAG Left hemisphere
Dissection Urgent cTAG Diffuse
Dissection Urgent TAG Unknown
Dissection Urgent TAG Left hemisphere
Dissection Elective TAG Right occipitalSpinal cord ischaemia. The overall rate of spinal cord
ischaemia was 6.1% (19/309). The details of the patients
who had spinal cord ischaemia are shown in Table 7. There
was no difference in the incidence of spinal cord ischaemia
between dissection (7/116) and aneurysm (12/193) patients
(6.0% vs. 6.2%, p ¼ 1.00, RR 1.030, CI 0.42e2.54).
Major adverse event rate. The overall incidence of a com-
bined end-point of death, stroke, or spinal cord ischaemia
was 16.8% (52/309). There was no signiﬁcant difference in
the overall major adverse event rate between dissection
(19/116) and aneurysm (33/193) patients (16.4% vs. 17.1%
respectively, p ¼ 1.00, RR 0.960, CI 0.57e1.60).DISCUSSION
This study has shown no difference between aneurysm and
dissection in the incidence of all-cause in-hospital mortality,
stroke, spinal cord ischaemia, and major adverse events for
patients undergoing thoracic endovascular repair. The ma-
jority of deaths in the aneurysm group were due to stroke,
mesenteric ischaemia, and myocardial infarction. TheVessels covered Revascularisation Outcome
None Alive
r Left subclavian None Dead
Left subclavian None Dead
None Dead
Left subclavian None Dead
None Alive
None Alive
Left subclavian None Dead
None Alive
None Alive
None Dead
Left subclavian None Alive
Left subclavian None Alive
Left subclavian None Alive
Left subclavian Carotid subclavian
bypass
Dead
None Dead
None None Alive
Left subclavian None Alive
Left subclavian None Alive
Table 7. Details of patients with spinal cord ischaemia.
Indication Presentation Device Arteries covered Revascularisation Cerebrospinal
ﬂuid drain
Neurological
outcome
Outcome
Aneurysm Elective TAG Left subclavian None Yes Recovered Alive
Aneurysm Elective TX2 None None Yes Recovered Alive
Aneurysm Elective TX2 None None Yes Recovered Alive
Aneurysm Urgent Talent None None Yes Recovered Alive
Aneurysm Urgent TAG Left subclavian none Yes Recovered Alive
Aneurysm Elective TX2 Left subclavian None Yes Partial Alive
Aneurysm Elective TAG None None Yes Partial Dead
Aneurysm Elective Excluder Coeliac None Yes Permanent Alive
Aneurysm Elective TAG Left subclavian None Yes Permanent Alive
Aneurysm Elective TX2 None None Yes Permanent Alive
Aneurysm Elective cTAG Left subclavian Carotid subclavian
bypass
Yes Permanent Alive
Aneurysm Urgent cTAG Left subclavian
and left common carotid
Right to left carotid
bypass
Yes Permanent Alive
Dissection Elective Endoﬁt Left subclavian None Yes Recovered Alive
Dissection Urgent TAG None None Yes Recovered Alive
Dissection Urgent TAG None None Yes Recovered Alive
Dissection Urgent cTAG None Internal iliac
angioplasty
Yes Recovered Alive
Dissection Elective TX2 None Yes Permanent Alive
Dissection Urgent TAG Left subclavian None Yes Permanent Alive
Dissection Urgent TAG None None Yes Permanent Alive
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related; the incidence of aortic related death was four times
greater in dissection than in aneurysm, which is concerning
and needs to be assessed in a larger study.
In the Scientiﬁc Statement from the American Heart As-
sociation, the incidence of death and spinal cord ischaemia
with endovascular repair of type B aortic dissection was 0e
20.0% and 0e2.8% respectively (no information was given
regarding the incidence of stroke).6 The incidence of death,
spinal cord ischaemia, and stroke for endovascular treat-
ment of aneurysms was 0e9.0%, 0e4.4% and 0e13.4%
respectively. More recently, the Interdisciplinary Consensus
Document for endovascular management of acute type B
aortic dissection demonstrated an incidence of death, spinal
cord ischaemia, and stroke of 10.2%, 4.2% and 4.9%,
respectively, in 2,359 cases.7 Our data, which included both
acute and chronic dissection, are in line with the results of
these studies. The data from ﬁve registries has recently
been combined with data from a single centre, and the
results of endovascular treatment of aneurysm was
compared with dissection.8 Pathology has an effect on mid-
term outcome although the mode of presentation was an
important factor. Stroke was not related to pathology, but
spinal cord ischaemia was found mainly in the aneurysm
group.
Neurological complications limit the efﬁcacy of endo-
vascular repair and constitute a major source of morbidity
and mortality. Our study demonstrated no difference in the
rate of stroke and paraplegia between aneurysm and
dissection, which is in contrast to other series, which have
shown that these occur less frequently in dissection,
particularly chronic dissection.9e11 Some studies have
documented an association between aneurysms andembolisation during catheter and wire manipulation in the
aortic arch resulting in athero-embolic anterior circulation
stroke.12 In our series the incidence of stroke was approxi-
mately the same in both pathologies, and review of Table 6
demonstrates that both anterior and posterior circulation
events were present in both aneurysms and dissections.
Preoperative assessment of the degree of atherosclerosis
affecting the aortic arch may identify high-risk patients who
could beneﬁt from prophylactic measures to prevent stroke.
Stroke is a signiﬁcant predictor of death and effective
measures to prevent it will have a signiﬁcant beneﬁcial ef-
fect on outcome. Techniques to protect the cerebral circu-
lation include the placement of ﬁlters into the carotid
arteries or aortic arch, but these are not currently used in
clinical practice.13 Patients presenting with dissection were
more likely to require a device placed in the aortic arch than
aneurysm patients. We have previously published our re-
sults on neurological outcome following thoracic endovas-
cular repair and have shown that the only signiﬁcant risk
factor for stroke on multivariate analysis was deliberate
coverage of the left subclavian artery without
revascularisation.14
Disruption of the collateral blood supply can affect
perfusion of the spinal cord and patients with a greater
extent of aortic coverage are more susceptible to spinal
cord ischaemia. In our series patients with aneurysm
compared with dissection were treated with a greater
number of stent grafts and therefore had more aortic
coverage. No difference was seen in the incidence of spinal
cord ischaemia between the groups, which may be because
patients with dissection tended to have a proximal landing
zone and therefore coverage of the left subclavian artery.
This artery gives rise to the vertebral artery, which supplies
274 R.E. Clough et al.the anterior spinal artery and therefore the proximal
segment of the spinal cord. All grades of spinal cord
ischaemia were included in this analysis. The inclusion of all
patients with any degree of spinal cord ischaemia will have
a negative effect on the outcome, but we believe this gives
a more honest appraisal of endovascular repair.
The majority of the patients in this series (aneurysm and
dissection) were treated with a Gore device (Flagstaff, AZ,
USA): initially the Thoracic Excluder, and more recently the
TAG and cTAG. The Cook TX2 (Bloomington, IN, USA) was
used mainly in the treatment of aneurysms because early in
the series some patients with dissection treated with the
TX2 had retrograde type A dissection. This may have been
related to the barbs at the proximal end of the device that
are used in active ﬁxation. The endovascular devices used in
dissection were initially designed for use in aneurysmal
disease. However, the biomechanical properties of the
aortic wall are different in dissection compared with
aneurysm and there has been recent interest in develop-
ment of a thoracic endograft speciﬁcally for dissection. The
proximal extent of the device is frequently placed in the
aortic arch when treating dissection. This area is a biome-
chanical transition zone and an area with high-velocity
blood ﬂow.
There are many unanswered questions regarding patient
selection and the use of endografts in dissection: the de-
gree of oversizing of the device; should sizing measure-
ments be taken in systole or diastole; the optimum the
length of the device; and the timing of treatment after
presentation. Only patients that developed complications
related to dissection were included in this series, in accor-
dance with the best available evidence. In our study there
was a high rate of aortic related complications in dissection,
which were associated with aortic related death. The cur-
rent poor results in some individuals with dissection treated
with either medical or endovascular treatment underlines
the complexity of this disease and the limitations of current
data to guide management.6,7,15,16 These studies demon-
strate that with medical treatment survival can be as low as
50% at 5 years. Patients treated endovascularly are at risk of
procedure-related complications such as stroke and para-
plegia. In the longer term these individuals remain at risk of
aortic rupture, due either to continued perfusion of the
false lumen or dilation of the infradiaphragmatic segment,
both leading to aneurysm formation and rupture.17
Thoracic stent grafts undergo considerable remodelling
after deployment in dissection, in which the changes in the
true lumen diameter, and therefore the change in stent
graft diameter, can be substantial.18 Stent grafts deployed in
these situations exist in a dynamic state of continuous
geometric alteration, which may affect the durability of
repair. Further work using advanced imaging and compu-
tational modelling to evaluate the forces acting on stent
grafts and their relationship to geometry and blood ﬂow
will improve our understanding of this disease. Future
reporting standards may select new haemodynamic and
biomechanical parameters to assess outcome which are
speciﬁc for pathology rather than generic to the procedure.The introduction of compliant devices and the development
of disease speciﬁc endovascular devices may reduce these
complications and improve clinical outcome in the future.Limitations
The data presented in this manuscript represents over 14
years of a single-centre experience in the management of
patients with thoracic aortic aneurysm and dissection. Data
regarding preoperative risk factors were not included in the
database and therefore were not available for analysis and
inclusion in the manuscript. The tertiary nature of referrals
may introduce a bias due to late presentation and case
selection, and the expertise of a specialist referral centre
may not be applicable to less experienced centres. Although
our analyses have demonstrated no difference between
aneurysm and dissection, there is some heterogeneity in
the two populations and a sample size of 309 may be too
small to investigate patient and procedural factors. Our
ﬁndings may also have been affected by unknown con-
founders or under-reporting of events.FUNDING
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